Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Schein Pharmaceuticals, Inc. (now Watson Laboratories)

Schein Pharmaceutical, Inc. develops, manufacturers, markets and distributes generic pharmaceutical products and a line of specialty branded pharmaceuticals. The company's product line includes both solid dosage and sterile dosage generic product. The brand product group focuses on developing and commercializing proprietary pharmaceutical products in niche therapeutic areas. They merged with Watson Pharmaceuticals (Watson is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes brand and generic pharmaceutical products) in 2008.

Search Projects

  • Director, Microbiology